XORTX Therapeutics Inc • XRTX

Capital at risk.

About XORTX Therapeutics Inc
Ticker
info
XRTX
Trading on
info
NASDAQ
ISIN
info
CA98420Q2071
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Allen Warren Davidoff Ph.D.
Headquarters
info
3710 – 33rd Street NW, Calgary, AB, Canada, T2L 2M1
Employees
info
0
Website
info
xortx.com
XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy. It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance. The company is based in Calgary, Canada.
Metrics
BasicAdvanced
Market cap
info
$4.4M
P/E ratio
info
-
EPS
info
-$0.40
Dividend Yield
info
0.00%
Beta
info
-0.09
Forward P/E ratio
info
0.96
EBIDTA
info
$-2.4M
Ex dividend date
info
-
Price & volume
Market cap
info
$4.4M
Average daily volume
info
0.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0.96
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
2.24
Earnings
EPS
info
-$0.40
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-2.4M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
-0.09
52-week High
info
$1.79
52-week Low
info
$0.52
50-day moving average
info
$0.71
200-day moving average
info
$0.86
Short ratio
info
0.02
Short %
info
1.48%
Management effectiveness
ROE (TTM)
info
-94.63%
ROA (TTM)
info
-45.32%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
-97.20%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
7M
Float
info
6.3M
Insiders %
info
10.10%
Institutions %
info
4.01%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$13.80
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.81
-$0.41
-97.56%
Q4 • 24Missed
$0.04
-
-
Q1 • 25Beat
-$0.19
-
-
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-0.7M
-∞%
Q2 • 25
$0M
$-0.6M
-∞%
Q3 • 25
NaN%
-11.96%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$2.7M
$0.7M
25.95%
Q2 • 25
$3.9M
$1.2M
29.75%
Q3 • 25
42.85%
63.78%
14.65%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-0.8M
$-0M
$-0M
$-0.8M
Q2 • 25
$-0.6M
$-0M
$0.8M
$-0.6M
Q3 • 25
-21.76%
-74.86%
-1,881.01%
-23.85%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a XORTX Therapeutics Inc share?
Collapse

XORTX Therapeutics Inc shares are currently traded for undefined per share.

How many shares does XORTX Therapeutics Inc have?
Collapse

XORTX Therapeutics Inc currently has 7M shares.

Does XORTX Therapeutics Inc pay dividends?
Collapse

No, XORTX Therapeutics Inc doesn't pay dividends.

What is XORTX Therapeutics Inc 52 week high?
Collapse

XORTX Therapeutics Inc 52 week high is $1.79.

What is XORTX Therapeutics Inc 52 week low?
Collapse

XORTX Therapeutics Inc 52 week low is $0.52.

What is the 200-day moving average of XORTX Therapeutics Inc?
Collapse

XORTX Therapeutics Inc 200-day moving average is $0.86.

Who is XORTX Therapeutics Inc CEO?
Collapse

The CEO of XORTX Therapeutics Inc is Dr. Allen Warren Davidoff Ph.D..

How many employees XORTX Therapeutics Inc has?
Collapse

XORTX Therapeutics Inc has 0 employees.

What is the market cap of XORTX Therapeutics Inc?
Collapse

The market cap of XORTX Therapeutics Inc is $4.4M.

What is the P/E of XORTX Therapeutics Inc?
Collapse

The current P/E of XORTX Therapeutics Inc is null.

What is the EPS of XORTX Therapeutics Inc?
Collapse

The EPS of XORTX Therapeutics Inc is -$0.40.

What is the PEG Ratio of XORTX Therapeutics Inc?
Collapse

The PEG Ratio of XORTX Therapeutics Inc is null.

What do analysts say about XORTX Therapeutics Inc?
Collapse

According to the analysts XORTX Therapeutics Inc is considered a buy.